Step Two Valuation
Is 531509 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 531509 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate 531509's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate 531509's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 531509?
Key metric: As 531509 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is 531509's PS Ratio? | |
|---|---|
| PS Ratio | 4.9x |
| Sales | ₹26.83m |
| Market Cap | ₹132.30m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 4.8x |
| Enterprise Value/EBITDA | -6x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 531509's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 15.9x | ||
540481 Classic Leasing & Finance | 33.9x | n/a | ₹132.7m |
531341 Ashtasidhhi Industries | 9.6x | n/a | ₹133.7m |
506365 Chemo Pharma Laboratories | 6.4x | n/a | ₹119.9m |
511730 Avasara Finance | 13.8x | n/a | ₹171.6m |
531509 Step Two | 4.9x | n/a | ₹132.3m |
Price-To-Sales vs Peers: 531509 is good value based on its Price-To-Sales Ratio (4.9x) compared to the peer average (15.9x).
Price to Sales Ratio vs Industry
How does 531509's PS Ratio compare vs other companies in the IN Diversified Financial Industry?
Price-To-Sales vs Industry: 531509 is good value based on its Price-To-Sales Ratio (4.9x) compared to the Indian Diversified Financial industry average (9.7x).
Price to Sales Ratio vs Fair Ratio
What is 531509's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 4.9x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate 531509's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Manappuram Finance
₹131.6b
A gold loan non-banking financial company, provides retail credit products and financial services in India.
531213
₹155.45
7D
0.4%
1Y
2.6%
Aditya Birla Capital
₹498.2b
Through its subsidiaries, provides various financial products and services in India and internationally.
ABCAPITAL
₹191.24
7D
3.5%
1Y
12.4%
Aditya Birla Capital
₹498.2b
Through its subsidiaries, provides various financial products and services in India and internationally.
540691
₹191.25
7D
3.6%
1Y
12.4%